Grand Pharma
Grand Pharma, officially known as Grand Pharmaceutical Group Limited, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in China (CN). Established in 1998, the company has made significant strides in developing innovative healthcare solutions, focusing on areas such as oncology, anaesthesia, and cardiovascular health.
With a robust operational presence across various regions, Grand Pharma is dedicated to producing high-quality pharmaceutical products that meet stringent international standards. Their core offerings include a diverse range of prescription medications and over-the-counter products, distinguished by their commitment to research and development.
Recognised for its market leadership, Grand Pharma has achieved notable milestones, including strategic partnerships and expansions that enhance its competitive edge. The company continues to prioritise patient-centric solutions, solidifying its reputation as a trusted name in the global pharmaceutical landscape.
-18 vs industry average
Grand Pharma’s score of 20 is lower than 27% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Grand Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2024
Reported emissions
Scope 3 accounts for ••• of total emissions.
Grand Pharma's reported carbon emissions
Grand Pharma, headquartered in China and operating within the Pharmaceutical Preparation Manufacturing industry, reported Scope 1 and Scope 2 emissions for the year 2021. The company's Scope 1 emissions amounted to approximately 172 million kg CO2e, and its Scope 2 emissions were approximately 104 million kg CO2e. While specific Scope 3 emissions data for 2021 was not disclosed, Grand Pharma's emissions reporting for this period does not indicate a total calculated sum for all scopes. It is important to note that Grand Pharma's disclosed emissions data for 2021 is cascaded from its parent organisation, Grand Pharmaceutical (China) Co., Ltd. Further details on the company's climate commitments and reduction initiatives are not available in the provided information.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Grand Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Grand Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project